Based on the clinical evidence and the patient profiles where the compound appears most applicable, the following characteristics tend to describe good candidates for AOD 9604 evaluation when it is medically supervised: Patients with stubborn localized fat deposits that have not responded to diet and exercise, particularly visceral and lower abdominal fat Patients who cannot tolerate GLP-1 medications due to nausea, gastrointestinal side effects, or contraindications Active patients with reasonable baseline metabolic health who want a targeted lipolytic tool to complement their training and nutrition program Patients already on a peptide protocol who want to add a fat-targeting element to a GHK-Cu, NAD+, or sermorelin stack Patients who are not candidates for stimulant-based fat loss medications due to cardiovascular sensitivity, anxiety, or blood pressure concerns AOD 9604 is not appropriate as a standalone weight loss strategy for patients with significant obesity, insulin resistance, or metabolic syndrome
The benefits are often cumulativethe more consistent you are, the better you feel
During your consultation, well: Review your injury history and symptoms Analyze your labs (hormone levels, inflammation markers) Discuss your goals (injury healing, performance, sleep, etc.) Create a customized protocol with 1-3 peptides Monitor your progress and adjust as needed How We Verify Peptide Quality At Blueline Wellness Group, peptide therapy is about more than access
If your B12 level is low, restoring it may improve your energy, mood and overall wellbeing
Rate of consumption Taking shots or chugging drinks increases the amount of alcohol absorbed into the system
Led by Dr
